CFP and neoplasm: An abscopal response to SDT+anti-PD-L1 antibody therapy has been reported in a murine mouse cancer model using PEGylated CoFe2O4 nanoflowers (CFP) – a novel sonosensitiser – to augment combined SDT + chemodynamic therapy (CDT) where in vivo suppression of both primary and distant tumour growth was achieved [99].